The global Spatial Genomics & Transcriptomics Market size is expected to reach USD 675.34 Million by 2028 at a CAGR of 18.1% over the forecast period, according to the latest report by Reports and Data. Key factors driving market revenue growth include increasing prevalence of genetic disorders and chronic conditions such as cancers, neurological disorders, and rare diseases, which have boosted need for high-resolution multiplex assays and instruments, and this is expected to further drive developments in spatial-based technologies. Increasing application of spatial genomics and transcriptomics for drug discovery and biomarker identification is also a key factor expected to drive revenue growth of market over the forecast period. Significant funding to expand R&D activities in the field of spatial-based technology is expected to support market growth going ahead.
Spatial transcriptomics covers methods specifically designed to assign cell types to their specific locations across tissue samples. It allows determination of subcellular localization of mRNA molecules. Data obtained about spatial distribution of mRNA molecules allows researchers to study cellular heterogeneity in tissues, tumors, and immune cells. Spatial-profiling based solutions allows analysis of tissue microenvironment, tumor biology, and tissues biomarkers. Spatial genomics and transcriptomics offers key insights in the fields of oncology, immunology, cell and gene therapy, histology, and embryology.
Spatial genomics and transcriptomics are novel research fields that aim to fill the knowledge gap about cellular machinery, spatial organization, differentiations, and localization that occurs at genomic and transcriptomics level within each cell and in tissues. These techniques have significant potential in managing chronic and rare diseases and rising burden of chronic disease such as cancers and diabetes across the globe have boosted their application in drug discovery and development. This is expected to fuel revenue growth of market over the forecast period. However, lack of skilled professionals and low awareness about advanced spatial-based technologies can restrain market growth to a significant extent over the forecast period.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3964
Key findings in the report:
Spatial Genomics & Transcriptomics Market Size, Share & Analysis, By Technique, By Product, By Application, By End-user, And By Region, Forecast To 2028, To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/spatial-genomics-and-transcriptomics-market
For the purpose of this report, Reports and Data has segmented the global spatial genomics & transcriptomics market based on technique, product application, end-use industry, and region:
Technique Outlook (Revenue, USD Million; 2018-2028)
Product Outlook (Revenue, USD Million; 2018-2028)
Application Outlook (Revenue, USD Million; 2018-2028)
End-user Outlook (Revenue, USD Million; 2018-2028)
Order Now: https://www.reportsanddata.com/checkout-form/3964
Regional Outlook (Revenue in USD Billion; 2017–2028)
Table Of Content
Chapter 1 Spatial Genomics & Transcriptomics Market: Methodology And Scope
1.1 Research Methodology
1.2 Research Assumptions
Chapter 2 Spatial Genomics & Transcriptomics Market: Executive Summary
2.1 Market Summary, 2021
Chapter 3 Spatial Genomics & Transcriptomics Market: Industry Outlook
3.1 Industry Pyramid Analysis
3.2 Market Segmentation & Scope
……………..
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1.2 Spatial Transcriptomics
8.3.1.2.1 Company overview
8.3.1.3 Financial Performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Dovetail Genomics
8.3.2.1 Company overview
8.3.2.2 Financial Performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Illumina, Inc.
8.3.3.1 Company overview
8.3.3.2 Financial Performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 S2 Genomics, Inc.
8.3.4.1 Company overview
8.3.4.2 Financial Performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 NanoString Technologies, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial Performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
Continue …
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Media ContactCompany Name: Reports and DataContact Person: John WatsonEmail: Send EmailPhone: +1-212-710-1370Address:40 Wall St. 28th floor City: New York CityState: NY 10005Country: United StatesWebsite: https://www.reportsanddata.com/report-detail/spatial-genomics-and-transcriptomics-market